BRD9 and prostate carcinoma: Although a study showed that CTCF binding is not affected by chemical BRD9 inhibition and ncBAF is not required for establishing CTCF sites in prostate cancer cell lines59, the precise effects of BRD9/ncBAF on CTCF localization have been poorly understood and might be context-dependent.